Xometry (NASDAQ:XMTR) Price Target Cut to $65.00 by Analysts at Citigroup

Xometry (NASDAQ:XMTRGet Free Report) had its price target cut by stock analysts at Citigroup from $75.00 to $65.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Citigroup’s price objective indicates a potential upside of 59.10% from the stock’s current price.

Several other brokerages have also issued reports on XMTR. JPMorgan Chase & Co. increased their target price on shares of Xometry from $55.00 to $70.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 5th. Cantor Fitzgerald boosted their target price on Xometry from $41.00 to $60.00 and gave the company a “neutral” rating in a research report on Wednesday, November 5th. William Blair reaffirmed an “outperform” rating on shares of Xometry in a research note on Tuesday. Citizens Jmp set a $75.00 price objective on Xometry in a research note on Wednesday, November 5th. Finally, The Goldman Sachs Group boosted their price objective on Xometry from $49.00 to $56.00 and gave the company a “neutral” rating in a report on Wednesday, November 5th. Five analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $60.13.

Read Our Latest Report on XMTR

Xometry Trading Down 8.1%

XMTR traded down $3.58 during trading on Wednesday, reaching $40.86. 2,037,751 shares of the stock traded hands, compared to its average volume of 1,045,957. The stock’s 50-day moving average is $61.69 and its 200 day moving average is $56.21. Xometry has a 12 month low of $18.59 and a 12 month high of $73.87. The company has a quick ratio of 3.58, a current ratio of 3.62 and a debt-to-equity ratio of 1.20. The stock has a market capitalization of $2.09 billion, a PE ratio of -32.58 and a beta of 0.86.

Xometry (NASDAQ:XMTRGet Free Report) last announced its earnings results on Tuesday, February 24th. The company reported $0.16 EPS for the quarter, beating the consensus estimate of $0.12 by $0.04. The company had revenue of $192.40 million for the quarter, compared to analyst estimates of $183.37 million. Xometry had a negative return on equity of 6.59% and a negative net margin of 9.80%.The firm’s revenue for the quarter was up 29.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.06 EPS. Equities analysts anticipate that Xometry will post -0.66 earnings per share for the current year.

Insiders Place Their Bets

In other Xometry news, CTO Vaidyanathan Raghavan sold 3,570 shares of Xometry stock in a transaction on Monday, January 5th. The shares were sold at an average price of $66.51, for a total transaction of $237,440.70. Following the transaction, the chief technology officer directly owned 38,397 shares of the company’s stock, valued at $2,553,784.47. The trade was a 8.51% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, President Sanjeev Singh Sahni sold 26,190 shares of Xometry stock in a transaction dated Thursday, January 8th. The stock was sold at an average price of $65.47, for a total transaction of $1,714,659.30. Following the completion of the sale, the president directly owned 63,130 shares in the company, valued at approximately $4,133,121.10. This represents a 29.32% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 63,861 shares of company stock worth $4,213,697 in the last three months. 9.66% of the stock is owned by corporate insiders.

Institutional Trading of Xometry

Several hedge funds and other institutional investors have recently made changes to their positions in XMTR. T. Rowe Price Investment Management Inc. bought a new position in shares of Xometry in the fourth quarter worth approximately $15,938,000. Fuller & Thaler Asset Management Inc. purchased a new stake in Xometry during the 4th quarter valued at $76,393,000. XTX Topco Ltd bought a new position in shares of Xometry during the 4th quarter valued at $1,440,000. Numerai GP LLC boosted its stake in shares of Xometry by 24.7% in the 4th quarter. Numerai GP LLC now owns 7,510 shares of the company’s stock worth $447,000 after buying an additional 1,487 shares during the last quarter. Finally, Odyssean LLC bought a new stake in shares of Xometry in the fourth quarter worth $663,000. Hedge funds and other institutional investors own 97.31% of the company’s stock.

Key Xometry News

Here are the key news stories impacting Xometry this week:

  • Positive Sentiment: Reported record Q4 revenue of roughly $192M (≈+30% YoY) and beat top‑line estimates, demonstrating marketplace and enterprise momentum. GlobeNewswire Press Release
  • Positive Sentiment: Company set a growth outlook (at least ~21% revenue growth for 2026) and highlighted expanding enterprise adoption — supportive for medium‑term revenue trajectory. Seeking Alpha
  • Positive Sentiment: Announced a planned CEO succession with leadership transition details; a structured plan reduces some governance uncertainty and can reassure institutional holders. Yahoo Finance
  • Positive Sentiment: Q1 revenue guidance was updated to $187–$189M vs. consensus ~$184.6M, implying continued growth into 1Q and providing some near‑term support. Company Slides / Press Materials
  • Neutral Sentiment: Management held an earnings call and provided a slide deck and transcript; investors will parse commentary for margin trajectory and enterprise mix — not a clear directional catalyst by itself. Conference Call Slides
  • Negative Sentiment: Two brokerages lowered price targets on 2/25 (RBC: $64→$55, sector perform; Wedbush: $70→$60, still outperform). PT cuts and note headlines pressured sentiment despite remaining upside in the new targets. TickerReport – RBC
  • Negative Sentiment: Another analyst price‑target cut reported (Wedbush) further weighed on the trade and likely contributed to intraday selling. TickerReport – Wedbush
  • Negative Sentiment: Some outlets/transcripts circulated a conflicting EPS report (one transcript reported a miss / negative EPS), creating confusion vs. other reports that showed an EPS beat; that discrepancy can amplify volatility as traders react to headline noise. InsiderMonkey Transcript

Xometry Company Profile

(Get Free Report)

Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.

Featured Stories

Analyst Recommendations for Xometry (NASDAQ:XMTR)

Receive News & Ratings for Xometry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xometry and related companies with MarketBeat.com's FREE daily email newsletter.